PHLDA2 Human

Pleckstrin homology-like domain family A member 2 Human Recombinant
Cat. No.
BT6928
Source
Escherichia Coli.
Synonyms
Pleckstrin homology-like domain family A member 2, Imprinted in placenta and liver protein, Tumor-suppressing subchromosomal transferable fragment candidate gene 3 protein, Tumor-suppressing STF cDNA 3 protein, Beckwith-Wiedemann syndrome chromosomal region 1 candidate gene C protein, p17-Beckwith-Wiedemann region 1 C, PHLDA2, BWR1C, HLDA2, IPL, TSSC3, BRW1C.
Appearance
Sterile filtered colorless solution.
Purity

Greater than 85% as determined by SDS-PAGE.

Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. They may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

PHLDA2 Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 172 amino acids (1-152 a.a.) and having a molecular mass of 19.2 kDa. PHLDA2 is fused to 20 amino acid His Tag at N-terminus and purified by proprietary chromatographic techniques.

Product Specs

Introduction
Pleckstrin homology-like domain family A member 2 (PHLDA2) is a cytoplasmic protein that plays a role in fetal and placental growth. It functions as an apoptosis-related protein and a negative growth regulator, with expression observed during normal human development. PHLDA2 exhibits imprinting in placenta, liver, and fetal tissues during embryogenesis, disappearing after development is complete. Located within the imprinted gene domain of 11p15.5, the PHLDA2 gene is among several genes considered vital for tumor suppression. Alterations in this region might be connected to conditions such as Beckwith-Wiedemann syndrome, Wilms tumor, rhabdomyosarcoma, adrenocortical carcinoma, and cancers of the lung, ovary, and breast. PHLDA2 expression is detected in the placenta (present in all villous cytotrophoblast cells), adult prostate gland, adult brain, and cell lines of neuroblastoma, medullablastoma, and glioblastoma. Low levels of expression are also observed in the adult liver and lung, as well as in the fetal liver.
Description
Recombinant human PHLDA2, produced in E. coli, is a single, non-glycosylated polypeptide chain consisting of 172 amino acids (residues 1-152) with a molecular weight of 19.2 kDa. A 20 amino acid His Tag is fused to the N-terminus of PHLDA2. The protein is purified using proprietary chromatographic methods.
Physical Appearance
A clear, colorless solution that has been sterilized by filtration.
Formulation
PHLDA2 is supplied in a solution at a concentration of 0.5 mg/ml. The solution also contains 20 mM Tris-HCl buffer (pH 8.0), 20% glycerol, 0.1 M NaCl, and 1 mM DTT.
Stability
While PHLDA2 Human Recombinant remains stable at 4°C for a week, it is recommended to store it at -18°C or below. Avoid repeated freeze-thaw cycles.
Purity
The purity of the protein is determined to be greater than 85% by SDS-PAGE analysis.
Synonyms
Pleckstrin homology-like domain family A member 2, Imprinted in placenta and liver protein, Tumor-suppressing subchromosomal transferable fragment candidate gene 3 protein, Tumor-suppressing STF cDNA 3 protein, Beckwith-Wiedemann syndrome chromosomal region 1 candidate gene C protein, p17-Beckwith-Wiedemann region 1 C, PHLDA2, BWR1C, HLDA2, IPL, TSSC3, BRW1C.
Source
Escherichia Coli.
Amino Acid Sequence

MGSSHHHHHH SSGLVPRGSH MKSPDEVLRE GELEKRSDSL FQLWKKKRGV LTSDRLSLFP ASPRARPKEL RFHSILKVDC VERTGKYVYF TIVTTDHKEI DFRCAGESCW NAAIALALID FQNRRALQDF RSRQERTAPA APAEDAVAAA AAAPSEPSEP SRPSPQPKPR TP.

Product Science Overview

Gene and Protein Structure

PHLDA2 is a protein-coding gene that plays a crucial role in regulating placental growth. The protein contains a Pleckstrin Homology (PH) domain, which is known for its ability to bind phosphoinositides and proteins, thereby influencing various cellular processes .

Function and Mechanism

PHLDA2 is involved in the regulation of placental growth by competing with other PH domain-containing proteins, preventing their binding to membrane lipids . This competition is essential for maintaining proper cellular functions and growth regulation. The gene is imprinted, meaning it is expressed preferentially from the maternal allele in the placenta and liver .

Clinical Significance

Alterations in the PHLDA2 gene region have been associated with several diseases, including Beckwith-Wiedemann Syndrome, Wilms tumor, rhabdomyosarcoma, adrenocortical carcinoma, and various cancers such as lung, ovarian, and breast cancer . The gene’s role in these conditions highlights its importance as a tumor suppressor.

Research and Applications

Research on PHLDA2 has shown its potential as a target for therapeutic interventions, especially in cancer treatment. The recombinant form of this protein is used in various studies to understand its function and mechanism better, providing insights into potential therapeutic strategies .

Summary

PHLDA2 is a vital protein with significant roles in placental growth regulation and tumor suppression. Its involvement in various diseases makes it a critical target for research and potential therapeutic interventions.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.